Cargando…

FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription

FOXP2, a member of forkhead box transcription factor family, was first identified as a language-related gene that played an important role in language learning and facial movement. In addition, FOXP2 was also suggested regulating the progression of cancer cells. In previous studies, we found that FO...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuxiang, Chen, Taolin, Guo, Mingyue, Li, Yu, Zhang, Qian, Tan, Guixiang, Yu, Li, Tan, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947682/
https://www.ncbi.nlm.nih.gov/pubmed/33718155
http://dx.doi.org/10.3389/fonc.2021.605025
_version_ 1783663278369538048
author Liu, Yuxiang
Chen, Taolin
Guo, Mingyue
Li, Yu
Zhang, Qian
Tan, Guixiang
Yu, Li
Tan, Yongjun
author_facet Liu, Yuxiang
Chen, Taolin
Guo, Mingyue
Li, Yu
Zhang, Qian
Tan, Guixiang
Yu, Li
Tan, Yongjun
author_sort Liu, Yuxiang
collection PubMed
description FOXP2, a member of forkhead box transcription factor family, was first identified as a language-related gene that played an important role in language learning and facial movement. In addition, FOXP2 was also suggested regulating the progression of cancer cells. In previous studies, we found that FOXA2 inhibited epithelial-mesenchymal transition (EMT) in breast cancer cells. In this study, by identifying FOXA2-interacting proteins from FOXA2-pull-down cell lysates with Mass Spectrometry Analysis, we found that FOXP2 interacted with FOXA2. After confirming the interaction between FOXP2 and FOXA2 through Co-IP and immunofluorescence assays, we showed a correlated expression of FOXP2 and FOXA2 existing in clinical breast cancer samples. The overexpression of FOXP2 attenuated the mesenchymal phenotype whereas the stable knockdown of FOXP2 promoted EMT in breast cancer cells. Even though FOXP2 was believed to act as a transcriptional repressor in most cases, we found that FOXP2 could activate the expression of tumor suppressor PHF2. Meanwhile, we also found that FOXP2 could endogenously bind to the promoter of E-cadherin and activate its transcription. This transcriptional activity of FOXP2 relied on its interaction with FOXA2. Furthermore, the stable knockdown of FOXP2 enhanced the metastatic capacity of breast cancer cells in vivo. Together, the results suggested that FOXP2 could inhibit EMT by activating the transcription of certain genes, such as E-cadherin and PHF2, in concert with FOXA2 in breast cancer cells.
format Online
Article
Text
id pubmed-7947682
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79476822021-03-12 FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription Liu, Yuxiang Chen, Taolin Guo, Mingyue Li, Yu Zhang, Qian Tan, Guixiang Yu, Li Tan, Yongjun Front Oncol Oncology FOXP2, a member of forkhead box transcription factor family, was first identified as a language-related gene that played an important role in language learning and facial movement. In addition, FOXP2 was also suggested regulating the progression of cancer cells. In previous studies, we found that FOXA2 inhibited epithelial-mesenchymal transition (EMT) in breast cancer cells. In this study, by identifying FOXA2-interacting proteins from FOXA2-pull-down cell lysates with Mass Spectrometry Analysis, we found that FOXP2 interacted with FOXA2. After confirming the interaction between FOXP2 and FOXA2 through Co-IP and immunofluorescence assays, we showed a correlated expression of FOXP2 and FOXA2 existing in clinical breast cancer samples. The overexpression of FOXP2 attenuated the mesenchymal phenotype whereas the stable knockdown of FOXP2 promoted EMT in breast cancer cells. Even though FOXP2 was believed to act as a transcriptional repressor in most cases, we found that FOXP2 could activate the expression of tumor suppressor PHF2. Meanwhile, we also found that FOXP2 could endogenously bind to the promoter of E-cadherin and activate its transcription. This transcriptional activity of FOXP2 relied on its interaction with FOXA2. Furthermore, the stable knockdown of FOXP2 enhanced the metastatic capacity of breast cancer cells in vivo. Together, the results suggested that FOXP2 could inhibit EMT by activating the transcription of certain genes, such as E-cadherin and PHF2, in concert with FOXA2 in breast cancer cells. Frontiers Media S.A. 2021-02-25 /pmc/articles/PMC7947682/ /pubmed/33718155 http://dx.doi.org/10.3389/fonc.2021.605025 Text en Copyright © 2021 Liu, Chen, Guo, Li, Zhang, Tan, Yu and Tan http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Yuxiang
Chen, Taolin
Guo, Mingyue
Li, Yu
Zhang, Qian
Tan, Guixiang
Yu, Li
Tan, Yongjun
FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription
title FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription
title_full FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription
title_fullStr FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription
title_full_unstemmed FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription
title_short FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription
title_sort foxa2-interacting foxp2 prevents epithelial-mesenchymal transition of breast cancer cells by stimulating e-cadherin and phf2 transcription
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947682/
https://www.ncbi.nlm.nih.gov/pubmed/33718155
http://dx.doi.org/10.3389/fonc.2021.605025
work_keys_str_mv AT liuyuxiang foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription
AT chentaolin foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription
AT guomingyue foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription
AT liyu foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription
AT zhangqian foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription
AT tanguixiang foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription
AT yuli foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription
AT tanyongjun foxa2interactingfoxp2preventsepithelialmesenchymaltransitionofbreastcancercellsbystimulatingecadherinandphf2transcription